Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. UTI
UTI logo

UTI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Universal Technical Institute Inc (UTI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
40.350
1 Day change
4.13%
52 Week Range
45.740
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Universal Technical Institute Inc (UTI) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. While the company has positive long-term growth potential, recent insider and hedge fund activity, as well as the lack of strong technical or trading signals, suggest it is better to hold off on investing right now.

Technical Analysis

The MACD is negative and contracting, indicating bearish momentum. RSI is neutral at 54.392, showing no clear overbought or oversold conditions. Moving averages are converging, suggesting indecision in the market. Key resistance levels are at $43.771 and $45.871, with support at $36.971 and $34.871.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
10

Positive Catalysts

  • Analysts have raised price targets recently, citing strong execution and long-term growth potential. The addition of EV and hybrid vehicle courses to meet market demand is a forward-looking initiative.

Neutral/Negative Catalysts

  • Coliseum Capital Management sold all its holdings in UTI, signaling a lack of confidence. Hedge funds are also selling heavily, with a 295.72% increase in selling activity last quarter. No recent congress trading data is available, and technical indicators show no strong bullish signals.

Financial Performance

No financial data available for analysis due to an error.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Multiple analysts have raised price targets, with the highest at $49, citing strong execution and long-term growth potential. However, near-term earnings are expected to be pressured due to investments in new campuses and programs.

Wall Street analysts forecast UTI stock price to fall
5 Analyst Rating
Wall Street analysts forecast UTI stock price to fall
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 38.750
sliders
Low
36
Averages
37
High
38
Current: 38.750
sliders
Low
36
Averages
37
High
38
Barrington
Alexander Paris
Outperform
maintain
$36 -> $42
AI Analysis
2026-05-07
Reason
Barrington
Alexander Paris
Price Target
$36 -> $42
AI Analysis
2026-05-07
maintain
Outperform
Reason
Barrington analyst Alexander Paris raised the firm's price target on Universal Technical to $42 from $36 and keeps an Outperform rating on the shares. The company's fiscal Q2 report topped estimates, the analyst tells investors in a research note. The firm says that while Universal Technical's near-term investments will pressure earnings in fiscal 2026 and 2027, the company should see continued strong enrollment and earnings in 2028 and 2029.
Northland
NULL
to
Outperform
upgrade
$38 -> $41
2026-05-07
Reason
Northland
Price Target
$38 -> $41
2026-05-07
upgrade
NULL
to
Outperform
Reason
Northland raised the firm's price target on Universal Technical to $41 from $38 and keeps an Outperform rating on the shares. Underlying execution is "solid," the analyst tells investors following the company's fiscal Q2 report.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for UTI
Unlock Now

People Also Watch